Anagin, Inc.

Indianapolis, IN

UEI
Z4BEUHA1BTV8
CAGE
6UWV9
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1800 N Capitol Ave e504, Indianapolis, IN 46202, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics U44NS119284 National Institute of Neurological Disorders and Stroke (NIH) $11,045,306
Development of novel small molecule analgesics modulating the nnos-NOS1AP protein-protein interaction R44NS098885 National Institute of Neurological Disorders and Stroke (NIH) $2,871,437
High throughput screen to identify small molecule analgesics targeting nnos-NOS1AP protein-protein interactions R43NS098885 National Institutes of Health $367,687
Nnos-PSD95 inhibitors as novel treatments for TBI R43NS095489 National Institutes of Health $267,381
Novel treatment of posttraumatic stress disorder R44MH103936 National Institutes of Health $2,993,056

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Anagin, Inc. registered in SAM.gov?

Yes. Anagin, Inc.'s SAM.gov registration is active through April 27, 2027.

What is Anagin, Inc.'s most recent federal award?

Anagin, Inc.'s most recent federal grant award is Discovery of PSD95 protein-protein interaction inhibitors as novel non-opioid analgesics (U44NS119284), from National Institute of Neurological Disorders and Stroke (NIH), on March 1, 2021.

On GovTribe

See Anagin, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login